Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
British Journal of Cancer
|
July 29, 2010
A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit
A T Brunetto, D Sarker, D Papadatos-Pastos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2015
The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer
G Middleton, L R Crack, S Popat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2019
Optimizing panel-based tumor mutational burden (TMB) measurement
J Budczies, M Allgäuer, K Litchfield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
H A Azim, S Michiels, F Zagouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2016
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
M Jamal-Hanjani, G A Wilson, S Horswell, et al.
NPJ Precision Oncology
|
May 2, 2025
Kinome profiling reveals pathogenic variant specific protein signalling networks in MEN2 children with Medullary Thyroid Cancer
B Rix, R Chauhan, Z Masoumi, et al.
Oncogene
|
June 27, 2017
Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions
J Zámborszky, B Szikriszt, J Z Gervai, et al.
Oncogene
|
July 26, 2016
Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions
J Zámborszky, B Szikriszt, J Z Gervai, et al.
Investigational New Drugs
|
June 27, 2013
Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trial
S Y Moorcraft, I Chau, C Peckitt, et al.
Oncogene
|
November 10, 2015
RAD18, WRNIP1 and ATMIN promote ATM signalling in response to replication stress
N Kanu, T Zhang, R A Burrell, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
British Journal of Cancer
|
July 29, 2010
A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit
A T Brunetto, D Sarker, D Papadatos-Pastos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2015
The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer
G Middleton, L R Crack, S Popat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2019
Optimizing panel-based tumor mutational burden (TMB) measurement
J Budczies, M Allgäuer, K Litchfield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
H A Azim, S Michiels, F Zagouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2016
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
M Jamal-Hanjani, G A Wilson, S Horswell, et al.
NPJ Precision Oncology
|
May 2, 2025
Kinome profiling reveals pathogenic variant specific protein signalling networks in MEN2 children with Medullary Thyroid Cancer
B Rix, R Chauhan, Z Masoumi, et al.
Oncogene
|
June 27, 2017
Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions
J Zámborszky, B Szikriszt, J Z Gervai, et al.
Oncogene
|
July 26, 2016
Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions
J Zámborszky, B Szikriszt, J Z Gervai, et al.
Investigational New Drugs
|
June 27, 2013
Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trial
S Y Moorcraft, I Chau, C Peckitt, et al.
Oncogene
|
November 10, 2015
RAD18, WRNIP1 and ATMIN promote ATM signalling in response to replication stress
N Kanu, T Zhang, R A Burrell, et al.
Page
of 5